Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$250.00
Provider: GlobalData
$250.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Biohit Oyj Maintains FY 2012 and FY 2013 Guidance


Thursday, 25 Oct 2012 02:30am EDT 

Biohit Oyj announced that it expects the net sales (revenue) of the Group in the fiscal year 2012 to fall somewhat short of the net sales achieved in the fiscal year 2011. The Company expects to achieve a positive result during the fiscal year 2013 or in the first half of 2014. 

Company Quote

5.9
0.02 +0.34%
11 Jul 2014